Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study

被引：2
|
作者：
Cappellini, M. Domenica [1 ]
El-Beshlawy, Amal [2 ]
Porter, John B. [3 ]
Kattamis, Antonis [4 ]
Taylor, Kerry [5 ]
Rose, Christian [6 ]
Louw, Vernon J. [7 ]
El-Ali, Ali [8 ]
Martin, Nicolas [8 ]
Gattermann, Norbert [9 ]
机构：
[1] Univ Milan, Policlin Fdn IRCCS, Milan, Italy
[2] Cairo Univ, Cairo, Egypt
[3] UCL, London, England
[4] Univ Athens, Athens, Greece
[5] Mater Hosp, Brisbane, Qld, Australia
[6] Hop St Vincent de Paul, Lille, France
[7] Univ Free State, Bloemfontein, South Africa
[8] Novartis Pharma AG, Basel, Switzerland
[9] Univ Dusseldorf, D-40225 Dusseldorf, Germany
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.5182.5182
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5182
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload
    Deugnier, Yves
    Turlin, Bruno
    Dong, Victor
    Giannone, Vanessa
    Zhang, Yiyun
    Griffel, Louis
    Brissot, Pierre
    BLOOD, 2010, 116 (21) : 1734 - 1735
  • [2] TREATMENT WITH DEFERASIROX FOR NON-TRANSFUSIONAL IRON OVERLOAD IN PATIENTS WITH THALASSEMIA INTERMEDIA
    Ladis, V.
    Berdoussi, H.
    Kattamis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 509 - 509
  • [3] Gastrointestinal disturbances in iron-overloaded myelodysplastic syndromes patients receiving concomitant medications during deferasirox treatment
    Gattermann, N.
    Porter, J. B.
    Rose, C.
    Schmid, M.
    Vassilieff, D.
    Guerci-Bresler, A.
    Ganser, A.
    Taylor, K.
    Louw, V. J.
    El-Ali, A.
    Martin, N.
    Cappellini, M. D.
    LEUKEMIA RESEARCH, 2013, 37 : S106 - S106
  • [4] Safety of Deferasirox (Exjade®) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis Focusing On Renal Function
    Schmid, Mathias
    Cappellini, M. Domenica
    Porter, John B.
    Greenberg, Peter L.
    Lawniczek, Tomasz
    Glaser, Sabine
    Dong, Victor
    Gattermann, Norbert
    BLOOD, 2009, 114 (22) : 702 - 703
  • [5] LONG TERM EFFICACY AND SAFETY OF DEFERASIROX IN TRANSFUSION DEPENDENT MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WITH IRON OVERLOAD: RESULTS FROM THE EPIC EXTENSION STUDY
    Gattermann, N.
    Sanz, G.
    Finelli, C.
    Forni, G.
    Nobile, F.
    Schmid, M.
    Vassilieff, D.
    Guerci-Bresler, A.
    Ganser, A.
    El-Ali, A.
    Martin, Ni
    Rose, C.
    HAEMATOLOGICA, 2013, 98 : 179 - 180
  • [6] Iron overload in patients with MDS: Baseline data from studies of the once-daily oral iron chelator, deferasirox
    Baer, R.
    Esposito, J.
    Kang, B.
    Virkus, J.
    Paley, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 380
  • [7] CONIFER - Non-interventional study to evaluate therapy monitoring during Exjade® (Deferasirox) treatment of iron toxicity in MDS patients with transfusional iron overload in the course of treatment
    Tesch, H.
    Bruch, H. -R.
    Denacausse, Y.
    Hessling, J.
    Lerchenmueller, C.
    Michel, G.
    Schlag, R.
    Skoruba, A.
    Schneider-Schranz, C.
    Wolf, S.
    Schulte, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 116 - 116
  • [8] Treatment of transfusional iron overload with deferasirox in patients with low and intermediate-1 risk MDS: Results from a German multi-center trial
    Nolte, F.
    Hoechsmann, B.
    Luebbert, M.
    Platzbecker, U.
    Haase, D.
    Lueck, A.
    Gattermann, N.
    Giagounidis, A.
    May, C.
    Leismann, O.
    Junkes, A.
    Schumann, C.
    Hofmann, W. -K
    Schrezenmeier, H.
    ONKOLOGIE, 2011, 34 : 290 - 290
  • [9] A NON-INTERVENTIONAL OBSERVATIONAL STUDY ASSESSING SAFETY OF DEFERASIROX IN PATIENTS WITH HEMOGLOBINOPATHIES AND TRANSFUSIONAL IRON OVERLOAD: RESULTS FROM THE "ENERGY" STUDY
    Voskaridou, E.
    Dimopoulou, M.
    Drosou, M.
    Vini, D.
    Ladis, V.
    Kattamis, A.
    Economou, M.
    Vlachaki, E.
    Symeonidis, A.
    Kouraklis, A.
    Dimitriadou, E.
    Kapsali, E.
    Chatziliami, A.
    Fragodimitri, C.
    Lafioniatis, S.
    Karavas, A.
    Klironomos, E.
    Aggelaki, M.
    Calpaka, A.
    Kontogianni, K.
    Michos, A.
    Papageorgiou, U.
    Lafiatis, I.
    Adamopoulos, I.
    HAEMATOLOGICA, 2015, 100 : 590 - 591
  • [10] Deferasirox in MDS patients with transfusion-caused iron overload—a phase-II study
    Georgia Metzgeroth
    Dietmar Dinter
    Beate Schultheis
    Alexandra Dorn-Beineke
    Kira Lutz
    Oliver Leismann
    Rüdiger Hehlmann
    Jan Hastka
    Annals of Hematology, 2009, 88
12345